Close Menu

NEW YORK (GenomeWeb) – Immunexpress said today it has received 510(k) clearance from the US Food and Drug Administration for the use of its Septicyte Lab, an RNA-based blood test that helps clinicians determine whether an infection has caused a patient's systemic inflammation.

Immunexpress noted that being able to rapidly differentiate infection-positive systemic inflammation, or sepsis, from infection-negative systemic inflammation, or systemic inflammatory response syndrome (SIRS), can save lives and reduce healthcare costs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.